• Thu, March 27, 2014
  • Fri, March 28, 2014
  • Mon, March 31, 2014
  • Tue, April 1, 2014
  • Wed, April 2, 2014
  • Thu, April 3, 2014

Matthew Harrison Initiated (BIIB) at Buy and Held Target at $395 on, Mar 27th, 2014

Matthew Harrison of Morgan Stanley, Initiated "Biogen Inc." (BIIB) at Buy and Held Target at $395 on, Mar 27th, 2014.

Matthew has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $400 on, Friday, February 14th, 2014
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $415 on, Tuesday, January 28th, 2014
  • Christopher Marai of "Nomura" Initiated at Strong Buy and Held Target at $368 on, Wednesday, January 8th, 2014


Similar Stocks and Investing Publications